CUSIP: 00163UAD8
What is CUSIP 00163UAD8?
CUSIP 00163UAD8 identifies 00163UAD8 - AMAG PHARMACEUTICALS INC - NOTE 3.250% 6/0 in SEC 13F datasets.
Where can I see the latest institutional holders?
Use the ownership history tables below to review the newest available institutional filing periods.
Open recent reporting periods for CUSIP 00163UAD8:
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2020 Q4 | $0 | $0 | -$288,181,000 | 0 | |
| 2020 Q3 | $327,627,940 | $300,811,000 | +$2,692,371 | 90.07% | 20 |
| 2020 Q2 | $312,441,940 | $249,371,000 | -$2,707,429 | 79.01% | 21 |
| 2020 Q1 | $317,059,940 | $245,459,000 | +$8,999,303 | 77.05% | 22 |
| 2019 Q4 | $304,188,440 | $257,547,955 | -$780,102 | 84.14% | 24 |
| 2019 Q3 | $305,304,940 | $254,761,000 | -$162,879 | 82.44% | 23 |
| 2019 Q2 | $305,562,940 | $247,407,000 | +$14,069,480 | 80.08% | 26 |
| 2019 Q1 | $283,231,440 | $249,512,054 | -$3,064,656 | 87.0% | 28 |
| 2018 Q4 | $291,319,506 | $266,401,370 | -$2,780,250 | 91.43% | 28 |
| 2018 Q3 | $302,125,000 | $316,695,000 | +$4,316,712 | 104.85% | 26 |
| 2018 Q2 | $289,287,500 | $297,889,550 | -$2,098,020 | 102.67% | 27 |
| 2018 Q1 | $291,464,000 | $300,997,153 | +$8,064,568 | 103.06% | 33 |
| 2017 Q4 | $292,370,000 | $251,949,000 | -$2,117,878 | 86.12% | 32 |
| 2017 Q3 | $290,390,000 | $282,871,000 | -$23,277,339 | 97.25% | 34 |
| 2017 Q2 | $314,557,000 | $302,501,000 | +$302,500,500 | 96.12% | 34 |